Search Within

Adult Leukemia

Formats
  1. Meeting Abstract (1797)
  2. Journal Article (1603)
  3. Review (122)
  4. Research Letter (55)
  5. Editorial (49)
  6. Book Section (39)
  7. Guidelines (20)
  8. Conference Paper (18)
  9. Correspondence (13)
  10. Miscellaneous (3)
  11. Book Whole (1)
Groups
  1. Center for Hematologic Malignancies (3720)
  2. Department of Medicine (3689)
  3. Hematologic Malignancies, Division of (3685)
  4. GSK Faculty (1783)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (1378)
  6. Executive Committee, Center for Hematologic Malignancies (970)

More Groups

People
  1. Ross Levine (787)
  2. Martin Tallman (655)
  3. David Scheinberg (502)
  4. Jae Park (387)
  5. Eytan Stein (371)
  6. Raajit Rampal (352)

More People

Years
  1. 2025 (103)
  2. 2024 (196)
  3. 2023 (233)
  4. 2022 (255)
  5. 2021 (248)
  6. 2020 (273)

More Years

Publications
  1. Blood (1254)
  2. Journal of Clinical Oncology (217)
  3. Clinical Lymphoma, Myeloma and Leukemia (117)
  4. Leukemia (110)
  5. Haematologica (107)
  6. Cancer Research (86)

More Publications

Publishers
  1. American Society of Hematology (1345)
  2. Nature Publishing Group (324)
  3. Elsevier Inc. (255)
  4. American Association for Cancer Research (234)
  5. American Society of Clinical Oncology (230)
  6. Ferrata Storti Foundation (107)

More Publishers

Results (3720)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The post-transplant scoring system (PTSS) is associated with outcomes in patients with MDS after CD34+ selected allogeneic stem cell transplant
    Journal Article

    Alarcon Tomas, A.; Whiting, K.; Maloy, M.; Ruiz, J. D.; Devlin, S.; Sanchez-Escamilla, M.; YanĖƒez, L.; Castillo, N.; Pennisi, M.; Cho, C.; more...
    Bone Marrow Transplantation (2021)

    Fulltext@MSK | Save
  • Tipifarnib as maintenance therapy did not improve disease-free survival in patients with acute myelogenous leukemia at high risk of relapse: Results of the phase III randomized E2902 trial
    Journal Article

    Luger, S. M.; Wang, V. X.; Rowe, J. M.; Litzow, M. R.; Paietta, E.; Ketterling, R. P.; Lazarus, H.; Rybka, W. B.; Craig, M. D.; Karp, J.; more...
    Leukemia Research (2021)

    Fulltext@MSK | Save
  • Enasidenib plus azacitidine versus azacitidine alone in patients with newly diagnosed, mutant-IDH2 acute myeloid leukaemia (AG221-AML-005): A single-arm, phase 1b and randomised, phase 2 trial
    Journal Article

    DiNardo, C. D.; Schuh, A. C.; Stein, E. M.; Montesinos, P.; Wei, A. H.; de Botton, S.; Zeidan, A. M.; Fathi, A. T.; Kantarjian, H. M.; Bennett, J. M.; more...
    Lancet Oncology (2021)

    Fulltext@MSK | Save
  • Harnessing the benefits of available targeted therapies in acute myeloid leukaemia
    Review

    Kantarjian, H.; Short, N. J.; DiNardo, C.; Stein, E. M.; Daver, N.; Perl, A. E.; Wang, E. S.; Wei, A.; Tallman, M.
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial
    Journal Article

    Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Open-label phase II prospective, randomized, controlled study of romyelocel-L myeloid progenitor cells to reduce infection during induction chemotherapy for acute myeloid leukemia
    Journal Article

    Desai, P. M.; Brown, J.; Gill, S.; Solh, M. M.; Akard, L. P.; Hsu, J. W.; Ustun, C.; Andreadis, C.; Frankfurt, O.; Foran, J. M.; more...
    Journal of Clinical Oncology (2021)

    Fulltext@MSK | Save
  • Maintenance therapies in acute myeloid leukemia: The renaissance of an old therapeutic concept
    Review

    Bewersdorf, J. P.; Tallman, M. S.; Stahl, M.
    Current Opinion in Oncology (2021)

    Fulltext@MSK | Save
  • TP53 combined phenotype score is associated with the clinical outcome of TP53-mutated myelodysplastic syndromes
    Journal Article

    Yabe, M.; Omarbekova, A. Z.; Hsu, M.; May, H.; Arcila, M. E.; Liu, Y.; Dogan, A.; Brunner, A. M.; Nardi, V.; Hasserjian, R. P.; more...
    Cancers (2021)

    Fulltext@MSK | Save
  • Ponatinib dose-ranging study in chronic-phase chronic myeloid leukemia: A randomized, open-label phase 2 clinical trial
    Journal Article

    Cortes, J.; Apperley, J.; Lomaia, E.; Moiraghi, B.; Undurraga Sutton, M.; Pavlovsky, C.; Chuah, C.; Sacha, T.; Lipton, J. H.; Schiffer, C. A.; more...
    Blood (2021)

    Fulltext@MSK | Save
  • COVID-19 in patients with CLL: Improved survival outcomes and update on management strategies
    Research Letter

    Roeker, L. E.; Eyre, T. A.; Thompson, M. C.; Lamanna, N.; Coltoff, A. R.; Davids, M. S.; Baker, P. O.; Leslie, L.; Rogers, K. A.; Allan, J. N.; more...
    Blood (2021)

    Fulltext@MSK | Save